ストックスクリーナーアプリを入手
1.25
0.00%
0.00
アフターアワーズ：
1.28
0.03
+2.40%
前日終値:
$1.25
開ける：
$1.29
24時間の取引高:
132.82K
Relative Volume:
0.22
時価総額：
$31.30M
収益：
-
当期純損益:
$-13.76M
株価収益率:
-1.3441
EPS:
-0.93
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.79%
1か月 パフォーマンス:
+17.92%
6か月 パフォーマンス:
+34.42%
1年 パフォーマンス:
-1.57%
1日の値動き範囲:
$1.20
$1.30
1週間の範囲:
$1.15
$1.30
52週間の値動き範囲:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
NRSN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.25 | 31.30M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd (NRSN) 最新ニュース
Will NeuroSense Therapeutics Ltd. Equity Warrant bounce back from current supportJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-09-30 20:29:52 - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Why NeuroSense Therapeutics Ltd. stock is rated strong buyWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Market Mood & Accurate Intraday Trade Tips - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increases2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Heatmap analysis for NeuroSense Therapeutics Ltd. Equity Warrant and competitorsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedQuarterly Earnings Summary & Low Risk Entry Point Guides - newser.com
Is NeuroSense Therapeutics Ltd. Equity Warrant stock undervalued vs historical averagesWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yieldQuarterly Portfolio Review & Precise Trade Entry Recommendations - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
What drives NeuroSense Therapeutics Ltd stock priceEx-Dividend Date Alerts & Fast Growing Investment Ideas - earlytimes.in
Leading vs lagging indicators on NeuroSense Therapeutics Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Published on: 2025-09-29 10:10:33 - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock is a must watch ticker2025 Big Picture & Long-Term Growth Stock Strategies - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsExit Point & Fast Gaining Stock Strategy Reports - newser.com
Published on: 2025-09-29 04:29:55 - newser.com
Why hedge funds are buying NeuroSense Therapeutics Ltd. Equity Warrant stock2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-09-29 00:44:31 - newser.com
Is NeuroSense Therapeutics Ltd Equity Warrant a good long term investmentDay Trading Setups & Free Discover Fast Growing Stocks - earlytimes.in
What drives NeuroSense Therapeutics Ltd H1Z stock priceFibonacci Retracement Levels & Free Expert Stock Watchlists - earlytimes.in
Will a bounce in NeuroSense Therapeutics Ltd. offer an exitExit Point & AI Powered Buy/Sell Recommendations - newser.com
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they mean2025 Price Targets & Risk Controlled Daily Plans - newser.com
Neurosense Therapeutics Ltd (NRSN) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):